admin

Making sense out of missense mutations

SFARI launched a request for applications in early 2015 that sought proposals to develop medium- and high-throughput screens to test the functional effects of de novo missense variants identified in the Simons Simplex Collection and other autism cohorts. Here, SFARI Senior Scientist Alan Packer discusses the proposals that were selected for funding as well as highlighting recent papers that have provided functional evidence for missense variants contributing to autism and other disorders.

  • Previous Page
  • Viewing
  • Next Page
Subscribe to our newsletter and receive SFARI funding announcements and news

privacy consent banner

Privacy preference

We use cookies to provide you with the best online experience. By clicking "Accept All," you help us understand how our site is used and enhance its performance. You can change your choice at any time here. To learn more, please visit our Privacy Policy.